Comparison of physical interventions, behavioral interventions, natural health products, and pharmacologics to manage hot flashes in patients with breast or prostate cancer: Protocol for a systematic review incorporating network meta-analyses

Systematic Reviews

Volumn 4, Issue 1, 2015, Pages

  Hutton, Brian ^a,b   Yazdi, Fatemeh ^a   Bordeleau, Louise ^c   Morgan, Scott ^b   Cameron, Chris ^e   Kanji, Salmaan ^a   Fergusson, Dean ^a,b   Tricco, Andrea ^f   Straus, Sharon ^f   Skidmore, Becky ^a   Hersi, Mona ^a   Pratt, Misty ^a   Mazzarello, Sasha ^d   Brouwers, Melissa ^c   Moher, David ^a,b   Clemons, Mark ^d  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

^e Department of Data Analytics and Evidence Synthesis   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Breast cancer; Hot flash; Network meta analysis; Prostate cancer; Systematic review

Indexed keywords

ALPHA TOCOPHEROL; CITALOPRAM; CLONIDINE; DULOXETINE; ESCITALOPRAM; GABAPENTIN; ISOFLAVONE DERIVATIVE; NORADRENALIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ACTAEA RACEMOSA; ACUPUNCTURE; ANDROGEN THERAPY; ARTICLE; BEHAVIOR THERAPY; BREAST CANCER; CANCER SURVIVAL; COGNITIVE THERAPY; DEPRESSION; ESTROGEN THERAPY; EXERCISE; FLAX; GINSENG; HOT FLUSH; HUMAN; HYPNOSIS; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PHYSIOTHERAPY; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAXATION TRAINING; SLEEP QUALITY; SOYBEAN; SYSTEMATIC REVIEW; YOGA; ALTERNATIVE MEDICINE; BREAST TUMOR; COMPLICATION; FEMALE; HOT FLASHES; MALE; META ANALYSIS; METHODOLOGY; PROSTATE TUMOR;

BREAST NEOPLASMS; COMPLEMENTARY THERAPIES; FEMALE; HOT FLASHES; HUMANS; MALE; PROSTATIC NEOPLASMS; RESEARCH DESIGN;

EID: 84940023023     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/s13643-015-0099-y     Document Type: Article

References (40)

1. Canadian Cancer Society. Prostate Cancer Statistics. http://www.cancer.ca/en/cancer-information/cancer-type/prostate/statistics/?region=sk . Accessed on September 15, 2014.
2. Canadian Breast Cancer Foundation. Breast Cancer in Canada, 2013. 2014 http://www.cbcf.org/ontario/AboutBreastCancerMain/FactsStats/Pages/Breast-Cancer-Canada.aspx .
3. Cella D, Fallowfield L. Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy. Breast Cancer Res Treat. 2008;107:167-80.
4. Avis N. Breast cancer survivors and Hot flashes: the search for nonhormonal treatments. J Clin Oncol. 2008;28:5008-10.
5. Casper R, Yen S. Neuroendocrinology of menopausal flushes: a hypothesis of flush mechanism. Clin Endocrinol (Oxf). 1985;22:293-312.
6. Alekshun T, Patterson S. Management of hot flashes in men with prostate cancer treated with androgen deprivation therapy. Support Cancer Ther. 2006;4:30-7.
7. Rossouw J, Anderson G, Prentice R, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy post-menopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-33.
8. Bassil N, Alkaade S, Morley J. The benefits and risks of testosterone replacement therapy: a review. Ther Clin Risk Manag. 2009;5:427-48.
9. Morgentaler A. Testosterone therapy in men with prostate cancer: scientific and ethical considerations. J Urol. 2009;181:972-9.
10. Bhasin S, Cinningham G, Hayes F, Matsumoto A, Snyder P, Swerdloff R, et al. Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2006;91:1995-2010.
11. Kligman L, Younus J. Management of hot flashes in women with breast cancer. Curr Oncol. 2010;17:82-6.
12. Frisk J. Managing hot flushes in men after prostate cancer-a systematic review. Maturitas. 2010;65:15-22.
13. Moyad M. Complementary/alternative therapies for reducing hot flashes in prostate cancer patients: reevaluating the existing indirect data from studies of breast cancer and postmenopausal women. Urology. 2002;59:20-33.
14. Ioannidis J. Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. CMAJ. 2009;181:488-93.
15. Lu G, Ades A. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004;23:3105-24.
16. Catala-Lopez F, Tobias A, Cameron C, Moher D, Hutton B. Network meta-analysis for comparing treatment effects of multiple interventions: an introduction. Rheumatol Int. 2014;34:1489-96.
17. Sampson M, McGowan J, Cogo E, Grimshaw J, Moher D, Lefebvre C. An evidence-based practice guideline for the peer review of electronic search strategies. J Clin Epidemiol. 2009;62:944-52.
18. Carpenter J. The Hot Flash Related Daily Interference Scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manage. 2001;22:979-89.
19. Greene J. A factor analytic study of climacteric symptoms. J Psychosom Res. 1976;20:425-30.
20. Kupperman H, Blatt M, Wiesbader H, Filler W. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol Metab. 1953;13:688-703.
21. Radloff L. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
22. Bastien C, Vallieres A, Morin C. Validation of the insomnia severity index as an outcome measure for insomnia research. Sleep Med. 2001;2:297-307.
23. Kind P. The EuroQOL instrument: an index of health-related quality of life. Philedelphia, PA: Lippincott-Raven; 1996.
24. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2008;6:2008.
25. Higgins J, Altman D, Gotzsche P, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
26. Donegan S, Williamson P, D'Alessandro U, Tudur Smith C. Assessing the key assumptions of network meta-analysis: a review of methods. Res Synth Methods. 2013;4:291-323.
27. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. In: Higgins J and Green S, editors. The Cochrane Collaboration. England: John Wiley and Sons Ltd; 2008.
28. Dias S, Sutton AJ, Ades AE, Welton N. Evidence synthesis for decision making 2: a generalised linear modelling framework for pairwise and network meta-analysis of randomised controlled trials. Med Decis Making. 2013;33(5):607-17.
29. Thorlund K, Walter SD, Johnson B, Furukawa T, Guyatt G. Pooling health-related quality of life outcomes in meta-analysis-a tutorial and review of methods for enhancing interpretability. Res Synth Methods. 2012;2:188-203.
30. Johnston B, Thorlund K, Schunemann H, Xie F, Murad M, Montori V, et al. Improving the interpretation of quality of life evidence in meta-analyses: the application of minimal important difference units. Health Qual Life Outcomes. 2010;8:116.
31. Dias S, Welton N, Sutton A, Caldwell D, Lu G, Ades A. NICE DSU Technical Support Document 4: inconsistency in networks of evidence based on randomised controlled trials. 2011.
32. Salanti G, Marinho V, Higgins J. A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered. J Clin Epidemiol. 2009;62:857-64.
33. Dias S, Sutton A, Welton N, Ades A. Evidence synthesis for decision making 3: heterogeneity-subgroups, meta-regression, bias, and bias-adjustment. Med Decis Making. 2013;33:618-40.
34. Salanti G, Kavvoura F, Ioannidis J. Exploring the geometry of treatment networks. Ann Intern Med. 2008;148:544-53.
35. Hutton B, Salanti G, Caldwell D, Schmid C, Chaimani A, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of healthcare interventions: checklist and explanations. Ann Intern Med. 2015;162:777-84.
36. Salanti G, Ades A, Ioannidis J. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial. J Clin Epidemiol. 2011;64:163-71.
37. Tonelli A, Zein J, Ioannidis J. Geometry of the randomized evidence for treatments of pulmonary hypertension. Cardiovasc Ther. 2013;31:e138-46.
38. Rizos E, Salanti G, Kontoyiannis D, Ioannidis J. Homophily and co-occurrence patterns shape randomized trials agendas: illustration in antifungal agents. J Clin Epidemiol. 2011;64:830-42.
39. Kappagoda S, Ioannidis J. Neglected tropical diseases: survey and geometry of randomised evidence. BMJ. 2012;345:e6512.
40. Guyatt G, Thorlund K, Oxman A, Walter S, Patrick D, Furukawa T, et al. GRADE guidelines: 13. Preparing summary of findings tables and evidence profiles-continuous outcomes. J Clin Epidemiol. 2013;66:173-83.